Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | PDE10A | Q9Y233 | 3/20 | 0.40 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.38 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 2/20 | 0.36 |
| ▸ | PPARA | Q07869 | 2/20 | 0.36 |
| ▸ | CTSK | P43235 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.35 |
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.35 |
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22431758 | 0.83 | ATM (0.45) | ATML3MBTL1CYP1A2CYP2A6PDE10A | |
| SCHEMBL17573000 | 0.81 | ATM (0.46) | ATML3MBTL1CYP1A2CYP2A6PDE10A | |
| SCHEMBL3122540 | 0.76 | ATM (0.51) | ATML3MBTL1CYP1A2CYP2A6PDE10A | |
| SCHEMBL6114924 | 0.74 | ATM (0.57) | ATML3MBTL1CYP1A2CYP2A6PDE10A | |
| SCHEMBL19214856 | 0.74 | ATM (0.46) | ATML3MBTL1CYP1A2CYP2A6PDE10A | |
| SCHEMBL873512 | 0.74 | CYP1A2 (0.54) | ATML3MBTL1CYP1A2CYP2A6PDE10A | |
| SCHEMBL24668044 | 0.74 | L3MBTL1 (0.43) | ATML3MBTL1CYP1A2CYP2A6PDE10A | |
| SCHEMBL20061664 | 0.73 | ATM (0.49) | ATML3MBTL1CYP1A2CYP2A6PDE10A | |
| SCHEMBL3960304 | 0.73 | PTPRA (0.53) | CYP1A2TSHRCYP2C19ALDH1A1LMNA | |
| SCHEMBL3639839 | 0.73 | HTR2A (0.51) | ATML3MBTL1CYP1A2CYP2A6PDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8362463-B2 | Organometallic complexes | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-01-29 | — | — | US | claimed |
| US-20090206327-A1 | ORGANOMETALLIC COMPLEXES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-08-20 | — | — | US | claimed |
| EP-1859656-A2 | ORGANOMETALLIC COMPLEXES | E.I. du Pont de Nemours and Company (US) | 2007-11-28 | — | — | EP | claimed |
| WO-2006072002-A2 | ORGANOMETALLIC COMPLEXES | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2006-07-06 | — | — | WO | claimed |
| US-8362463-B2 | Organometallic complexes | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-01-29 | — | — | US | disclosed |
| US-20090206327-A1 | ORGANOMETALLIC COMPLEXES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-08-20 | — | — | US | disclosed |
| EP-1859656-A2 | ORGANOMETALLIC COMPLEXES | E.I. du Pont de Nemours and Company (US) | 2007-11-28 | — | — | EP | disclosed |
| WO-2006072002-A2 | ORGANOMETALLIC COMPLEXES | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2006-07-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090206327-A1 | ORGANOMETALLIC COMPLEXES | SLC25A11, TIMM9, TIMM50 | ATM 3135/4885L3MBTL1 1088/4885CYP1A2 2946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.